Bupropion Hydrobromide

6 indexed presentations.

Reference only for licensed healthcare facilities. These listings support NDC-level identification and quote review, and do not imply current stock, manufacturer sponsorship, or direct purchasing status. Review NDC-level listings, compare package configurations, and request a quote review when needed.

Need a Product Not Listed?

Submit a quote review for unlisted NDCs, item codes, or alternate product presentations.

Drug Directory A-Z | Drug names: B | Drug Search | Request a Quote Review

Generic details

Review dosage forms, strengths, package variations, and manufacturer identifiers associated with Bupropion Hydrobromide.

  • Indexed presentation count: 6 indexed presentations.
  • Common dosage forms: Tablet.

Common presentations

Compare presentation differences here, then open the table rows below for NDC-level confirmation.

  • Strength variation: 174 mg / 1, 348 mg / 1, and 522 mg / 1.
  • Package variation: 30 Tablet, Extended Release and 7 Tablet, Extended Release.
  • Manufacturer information is shown for product identification only.

Official references

Use official label-search references for this generic family when your team needs supplemental labeling context.

Showing page 1 of 1
Aplenzin - Bupropion hydrobromide 174 mg / 1 Tablet 30 Tablet, Extended Release00187-5810-30174 mg / 1Tablet30 Tablet, Extended Release
Aplenzin - Bupropion hydrobromide 174 mg / 1 Tablet 7 Tablet, Extended Release00187-5810-07174 mg / 1Tablet7 Tablet, Extended Release
Aplenzin - Bupropion hydrobromide 348 mg / 1 Tablet 30 Tablet, Extended Release00187-5811-30348 mg / 1Tablet30 Tablet, Extended Release
Aplenzin - Bupropion hydrobromide 348 mg / 1 Tablet 7 Tablet, Extended Release00187-5811-07348 mg / 1Tablet7 Tablet, Extended Release
Aplenzin - Bupropion hydrobromide 522 mg / 1 Tablet 30 Tablet, Extended Release00187-5812-30522 mg / 1Tablet30 Tablet, Extended Release
Aplenzin - Bupropion hydrobromide 522 mg / 1 Tablet 7 Tablet, Extended Release00187-5812-07522 mg / 1Tablet7 Tablet, Extended Release

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.